Recensioni verificate Soddisfatta del servizio.
Personale disponibile e gentile. Lo consiglio a tutti ...
Cliente Sorgente Genetica
logomysorgente

02  4948  5291

  • Cos'è AURORA

    Aurora è il test di screening prenatale di ultima generazione 
    sicuro, affidabile,
    veloce e precoce

  • Sicuro

    Grazie a un semplice prelievo di sangue materno
    eviti il rischio di aborto di tecniche invasive come amniocentesi o villocentesi

  • Affidabile

    Oltre il 99,9% di affidabilità nel rilevare
    la trisomia 21, responsabile
    della Sindrome di Down

  • Precoce e veloce

    icona svegliaIndividuare precocemente la presenza di anomalie cromosomiche è fondamentale:
    puoi effettuare Aurora dalla 10ª settimana

    icona documentoIl test è veloce: risultati in 7-10 giorni lavorativi con la percentuale di test da ripetere più bassa del mercato: 0,1%

  • La serenità della mamma
    in 3 semplici passi

    icotelefona

    Prenota il test

    icoesami

    Fai un prelievo di sangue

    icoginecologo

    Leggi i risultati

  • Test diagnosi prenatale non invasivo
  • 151126 banner Aurora mobile 01
  • 151126 banner Aurora mobile 02
  • 151126 banner Aurora mobile 03
  • slide mobile03
cover cartoon
cover venturetti

Ultime notizie dal mondo della genetica


Developed a new way to safeguard the fertility of young men

The testicular tissues of 189 young men show that fertility can survive chemotherapy with the right techniques. Dr. Hanna Valli-Pulaski's team analyzed the tissues taken for biopsies. Inside them there are sperm progenitor cells, which can be used to obtain gametes to be used for IVF.

Some children with cancer are too young to produce sperm to keep. Even the older ones, can have problems in this sense during the therapies, because of the stress. Until a few years ago, this would have denied them any chance of having children in adulthood. Indeed, chemotherapy tends to reduce or cancel subjects' fertility. Lastly, alternatives are emerging. The preservation of testicular tissue is one of these.

The tissues taken with biopsies contain stem cells, which could generate new spermatozoa. The study in question shows that these undifferentiated stem cells could also be obtained from those in the early stages of treatment. This therefore leaves a greater amount of time to act, in order to determine how to separate healthy and tumor cells present in the samples.

The study also includes meetings between doctors and patients' families focused only on future fertility. The goal is to analyze the benefits of post-cancer life and also promote alternatives that are currently little known. To date, only 39% of patients use a fertility preservation tool.

Source: eurekalert.org

Link social

Link social